Literature DB >> 24581731

Prostate biopsy for the interventional radiologist.

Cheng William Hong1, Hayet Amalou1, Sheng Xu1, Baris Turkbey2, Pingkun Yan3, Jochen Kruecker3, Peter A Pinto4, Peter L Choyke2, Bradford J Wood5.   

Abstract

Prostate biopsies are usually performed by urologists in the office setting using transrectal ultrasound (US) guidance. The current standard of care involves obtaining 10-14 cores from different anatomic sections. Biopsies are usually not directed into a specific lesion because most prostate cancers are not visible on transrectal US. Color Doppler, US contrast agents, elastography, magnetic resonance (MR) imaging, and MR imaging/US fusion are proposed as imaging methods to guide prostate biopsies. Prostate MR imaging and fusion biopsy create opportunities for diagnostic and interventional radiologists to play an increasingly important role in the screening, evaluation, diagnosis, targeted biopsy, surveillance, and focal therapy of patients with prostate cancer. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24581731      PMCID: PMC4308315          DOI: 10.1016/j.jvir.2013.12.568

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  55 in total

1.  Best practice policy statement on urologic surgery antimicrobial prophylaxis.

Authors:  J Stuart Wolf; Carol J Bennett; Roger R Dmochowski; Brent K Hollenbeck; Margaret S Pearle; Anthony J Schaeffer
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

Review 2.  Fine needle aspiration biopsy of the prostate gland.

Authors:  John A Maksem; Aasmund Berner; Carlos Bedrossian
Journal:  Diagn Cytopathol       Date:  2007-12       Impact factor: 1.582

3.  Screening and prostate-cancer mortality in a randomized European study.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

4.  Mortality results from a randomized prostate-cancer screening trial.

Authors:  Gerald L Andriole; E David Crawford; Robert L Grubb; Saundra S Buys; David Chia; Timothy R Church; Mona N Fouad; Edward P Gelmann; Paul A Kvale; Douglas J Reding; Joel L Weissfeld; Lance A Yokochi; Barbara O'Brien; Jonathan D Clapp; Joshua M Rathmell; Thomas L Riley; Richard B Hayes; Barnett S Kramer; Grant Izmirlian; Anthony B Miller; Paul F Pinsky; Philip C Prorok; John K Gohagan; Christine D Berg
Journal:  N Engl J Med       Date:  2009-03-18       Impact factor: 91.245

5.  The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?

Authors:  Joseph Feliciano; Ervin Teper; Michael Ferrandino; Richard J Macchia; William Blank; Ivan Grunberger; Ivan Colon
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

6.  Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score.

Authors:  Eric D Nelson; Craig B Slotoroff; Leonard G Gomella; Ethan J Halpern
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

7.  Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies.

Authors:  Sheng Xu; Jochen Kruecker; Baris Turkbey; Neil Glossop; Anurag K Singh; Peter Choyke; Peter Pinto; Bradford J Wood
Journal:  Comput Aided Surg       Date:  2008-09

Review 8.  Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

Authors:  Kenneth Lin; Robert Lipsitz; Therese Miller; Supriya Janakiraman
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

9.  Does transrectal ultrasound probe configuration really matter? End fire versus side fire probe prostate cancer detection rates.

Authors:  Christina B Ching; Ayman S Moussa; Jianbo Li; Brian R Lane; Craig Zippe; J Stephen Jones
Journal:  J Urol       Date:  2009-03-14       Impact factor: 7.450

Review 10.  MR-guided biopsy of the prostate: an overview of techniques and a systematic review.

Authors:  Kirsten M Pondman; Jurgen J Fütterer; Bennie ten Haken; Leo J Schultze Kool; J Alfred Witjes; Thomas Hambrock; Katarzyna J Macura; Jelle O Barentsz
Journal:  Eur Urol       Date:  2008-06-12       Impact factor: 20.096

View more
  3 in total

Review 1.  Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Authors:  Mohammad H Bagheri; Mark A Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A Malayeri; Piyush K Agarwal; Peter L Choyke; Les R Folio; Andrea B Apolo
Journal:  Urol Oncol       Date:  2017-05-12       Impact factor: 3.498

2.  Kinematic and mechanical modelling of a novel 4-DOF robotic needle guide for MRI-guided prostate intervention.

Authors:  Pradipta Biswas; Hossein Dehghani; Sakura Sikander; Sang-Eun Song
Journal:  Biomed Eng Adv       Date:  2022-05-24

3.  Evaluation of robot-assisted MRI-guided prostate biopsy: needle path analysis during clinical trials.

Authors:  Pedro Moreira; Niravkumar Patel; Marek Wartenberg; Gang Li; Kemal Tuncali; Tamas Heffter; Everette C Burdette; Iulian Iordachita; Gregory S Fischer; Nobuhiko Hata; Clare M Tempany; Junichi Tokuda
Journal:  Phys Med Biol       Date:  2018-10-16       Impact factor: 3.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.